Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $108

Benzinga · 10/14 14:00
Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $104 to $108.